The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Dialectic Therapeutics
Leadership - Dialectic Therapeutics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Bristol-Myers Squibb; Dialectic Therapeutics; Intuitive Surgical; Johnson & Johnson; Merck; Regeneron
Consulting or Advisory Role - Binhui Biopharmaceuticals, Ltd.; Synlogic
Research Funding - Agenus; Alkermes; Arvinas; AstraZeneca; BerGenBio; Daiichi Sankyo; Epizyme; Gan & Lee; Genmab; GlaxoSmithKline; Harpoon therapeutics; Hutchison MediPharma; Jounce Therapeutics; Laekna Therapeutics; Mirati Therapeutics; Mundipharma; Novartis Pharmaceuticals UK Ltd.; Odonate Therapeutics; Onconova Therapeutics; ORIC Pharmaceuticals; Pfizer; Rgenix; Shasqi Inc.; Surface Oncology; Synlogic; Takeda; Xencor
ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.
 
Valentina Boni
Honoraria - IDEAYA Biosciences; Loxo
Consulting or Advisory Role - Guidepoint Global; OncoArt
Speakers' Bureau - Solti
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Alkermes (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); BioNTech (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Genmab (Inst); Incyte (Inst); Janssen Oncology (Inst); Kura Oncology (Inst); Lilly (Inst); Loxo (Inst); Menarini (Inst); Merck (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Seagen (Inst); Synthon (Inst); Tesaro (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - START
 
Ira Seth Winer
Research Funding - Oncoceutics
 
Lucy Gilbert
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck
Consulting or Advisory Role - GlaxoSmithKline; Merck
Research Funding - Alkermes (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Immunogen (Inst); IMV (Inst); Inovio Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck; Pfizer
 
Ulka N. Vaishampayan
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EMD Serono; Exelixis; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Pfizer
 
Seth David Rosen
No Relationships to Disclose
 
Jameel Muzaffar
No Relationships to Disclose
 
Anna Spreafico
Honoraria - Bristol-Myers Squibb; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Oncorus
Research Funding - Alkermes; Array BioPharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Northern Biologics; Novartis; Replimune; Roche; Surface Oncology; Symphogen
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Idera; Janssen Oncology; Merck; Roche
 
David F. McDermott
Consulting or Advisory Role - alkermes; Array BioPharma; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; exelixis; Genentech/Roche; Iovance Biotherapeutics; Jounce Therapeutics; Lilly; Merck; Novartis; Peloton Therapeutics; Pfizer
Research Funding - alkermes (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Prometheus (Inst)
Other Relationship - Beth Israel Deaconess Medical Center
(OPTIONAL) Uncompensated Relationships - AVEO; X4 Pharma
 
Quincy S. Chu
Honoraria - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Olivier Dumas
No Relationships to Disclose
 
Aman Chauhan
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
(OPTIONAL) Uncompensated Relationships - Ipsen (Inst); Lexicon (Inst)
 
Arvind Chaudhry
Stock and Other Ownership Interests - Novartis
Honoraria - Bayer
Consulting or Advisory Role - Bayer
 
Piotr Tomczak, MD
No Relationships to Disclose
 
Debora S. Bruno
Consulting or Advisory Role - Tempus
 
Yangchun Du
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Ilda Bidollari
Employment - Alkermes
Leadership - Alkermes; Novartis; Teva
Stock and Other Ownership Interests - Alkermes; Teva
 
Jessicca Martin Rege
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
 
Marc S. Ernstoff
Stock and Other Ownership Interests - Bristol-Myers Squibb; GE Healthcare
Consulting or Advisory Role - Alkermes; Bristol-Myers Squibb; EMD Serono; ImmuNext; Omniseq
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); EMD Serono; Merck (Inst); Merrimack (Inst)
Travel, Accommodations, Expenses - Alkermes; ImmuNext
Other Relationship - Bristol-Myers Squibb
 
James F. Strauss
No Relationships to Disclose
 
Vamsidhar Velcheti
Consulting or Advisory Role - AstraZeneca/MedImmune; Boston Scientific; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; GlaxoSmithKline; Lilly; Merck; Novartis; Novocure
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)